TBIO: Telesis Bio Inc. Price Target Chart
Telesis Bio, Inc. (TBIO) is implementing BioXp autonomous systems for high-precision gene synthesis without human intervention. Such solutions reduce environmental impact by eliminating the transport of chemicals. The current metric stands at 72.15. The company's price chart reflects the dynamics of a synthetic biology leader whose biotech dominance is sustained by massive R&D expenditures.
Metric breakdowns and analytics for Codex DNA (TBIO)
- stock quotes and analyst forecast:
- market capitalization information:
- issuer book value statistics:
- debt obligations and liquidity statistics:
Debt to Equity Ratio Telesis Bio, Inc.|TBIO - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Telesis Bio, Inc|TBIO - Company Aggregate Debts|Debts to Book Capitalization Codex DNA|TBIO - Company Long-Term Liabilities|Amount of Current Liabilities Telesis Bio|Immediate Liquidity telesisbio.com
- net income and valuation ratios data:
TBIO - Company Net Income|Expected Profit Telesis Bio, Inc.|TBIO - P/E Multiple|Projected Price to Earnings Ratio Telesis Bio Inc.|TBIO - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Codex DNA|TBIO - Operating profit EBITDA|Net earnings per share for the last four quarters Telesis Bio|TBIO - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months telesisbio.com|TBIO - Net earnings per share growth this year|Expected earnings per share trend next year Telesis Bio, Inc.
General company analysis:TBIO telesisbio.com
Telesis Bio, Inc. (TBIO) monetizes DNA synthesis through the sale of equipment and high-margin consumables, creating sustainable operating leverage. The analyst consensus target for the stock aggregates average price targets from investment firms, measuring the market's fundamental confidence in the scalability of this model; the stability of this line confirms the asset's reliability, while sharp deviations signal a revision of the valuation of future cash flows.
Who Telesis Bio, Inc. competes with
Analyst Forecast Prices TEM|Analyst Consensus Forecast QGEN (Qiagen)|Ionis Pharmaceuticals, Inc. - Price Target Chart|Repligen Corp. - Analyst Consensus Forecast|Analyst Median Target Avidity Corp RNA|CRISPR Therapeutics AG (CRSP) - Price Target Chart|Average Forecast Price genedx.com (WGS)|RARE (Ultragenyx) - Analyst Consensus Forecast|Broker Consensus Forecast BEAM (Beam Therapeutics Inc)|Price Target Chart Sarepta Therapeutics Inc (SRPT)|Twist Bioscience Corp - Broker Consensus Forecast|Analyst Consensus Forecast TXG (10x Genomics, Inc.)|Analyst Consensus Forecast intelliatx.com NTLA|STOK: Consensus Target|BioLife Solutions Inc - Analyst Forecast Prices|WVE: Analyst Consensus Forecast|Average Forecast Price Maze Therapeutics Corp (MAZE)|Price Target Chart Sionna Therapeutics Inc|Price Target Chart PRME|Analyst Consensus Forecast TSHA|QURE - Average Forecast Price|Price Target Chart MeiraGTx PLC MGTX|Analyst Median Target REGENXBIO Corp (RGNX)|Solid Biosciences Inc. - Analyst Consensus Forecast|Analyst Median Target ocugen.com OCGN|PacBio (PACB) - Price Target Chart|BNTC - Analyst Median Target|Consensus Target DSGN|RCKT: Fair Value Consensus|Analyst Consensus Forecast FDMT|Price Target Chart LXEO (lexeotx.com)|Analyst Consensus Forecast KRRO (Korro Bio)|Analyst Median Target Editas Medicine Inc (EDIT)|SLN - Price Target Chart|Average Forecast Price ProQR Therapeutics N.V.|CDXS (codexis.com) - Consensus Target|sangamo.com - Fair Value Consensus|NAUT (Nautilus Biotechnology, Inc.) - Analyst Consensus Forecast|Metagenomi Inc. (MGX) - Analyst Median Target|Price Target Chart Precision BioSciences (DTIL)|generationbio.com - Broker Consensus Forecast|Analyst Consensus Forecast BOLD (Boundless Bio, Inc.)|XCUR - Consensus Target|IMNN: Consensus Target|Analyst Median Target Phio Pharmaceuticals PHIO|MBIO (mustangbio.com) - Consensus Target|RNAZ: Analyst Forecast Prices|BNGO (Bionano Genomics Inc.) - Analyst Consensus Forecast|Price Target Chart APDN|Analyst Consensus Forecast BLUE|Analyst Median Target immunoprecise.com|Price Target Chart Omega OMGA|Singular Genomics Corp (OMIC) - Average Forecast Price|Regulus Therapeutics - Analyst Consensus Forecast|SYRS (syros.com) - Broker Consensus Forecast|TRACON Pharmaceuticals, Inc. (TCON) - Price Target Chart|Broker Consensus Forecast UBX
